Loading...

Digital Transformation And AI Adoption Will Drive Global Healthcare Expansion

Published
30 May 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
US$70.50
23.8% undervalued intrinsic discount
04 Sep
US$53.73
Loading
1Y
408.3%
7D
5.2%

Author's Valuation

US$70.523.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on08 Aug 25
Fair value Increased 42%

Claritev’s future P/E has increased markedly while net profit margin has declined, indicating higher valuation despite weaker profitability, yet the consensus price target remains unchanged at $49.50. What's in the News Claritev updated full-year 2025 revenue guidance to flat to +2% versus 2024.

Shared on30 Jul 25
Fair value Increased 43%

The notable upward revision in Claritev’s consensus price target appears driven by a significant increase in its future P/E multiple despite a modest decline in net profit margin, resulting in a new fair value estimate of $47.00. What's in the News Claritev was added to several Russell indices, including Russell 2000, 2500, 3000, Microcap, and related growth/sector benchmarks, enhancing index weighting and potential passive inflows.